• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖合并慢性肾脏病管理中的障碍和机遇:美国肾脏病基金会和肥胖学会联合主办的科学研讨会报告。

Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society.

机构信息

Division of Nephrology, School of Medicine, Indiana University Indianapolis, Indiana, USA.

Pennington Biomedical Research Institute, Louisiana State University, Baton Rouge, Louisiana, USA.

出版信息

Obesity (Silver Spring). 2022 Dec;30(12):2340-2350. doi: 10.1002/oby.23599. Epub 2022 Oct 21.

DOI:10.1002/oby.23599
PMID:36268562
Abstract

The National Kidney Foundation (NKF) and The Obesity Society (TOS) cosponsored a multispecialty international workshop in April 2021 to advance the understanding and management of obesity in adults with chronic kidney disease (CKD). The underlying rationale for the workshop was the accumulating evidence that obesity is a major contributor to CKD and adverse outcomes in individuals with CKD, and that effective treatment of obesity, including lifestyle intervention, weight loss medications, and metabolic surgery, can have beneficial effects. The attendees included a range of experts in the areas of kidney disease, obesity medicine, endocrinology, diabetes, bariatric/metabolic surgery, endoscopy, transplant surgery, and nutrition, as well as patients with obesity and CKD. The group identified strategies to increase patient and provider engagement in obesity management, outlined a collaborative action plan to engage nephrologists and obesity medicine experts in obesity management, and identified research opportunities to address gaps in knowledge about the interaction between obesity and kidney disease. The workshop's conclusions help lay the groundwork for development of an effective, scientifically based, and multidisciplinary approach to the management of obesity in people with CKD.

摘要

美国肾脏基金会(NKF)和肥胖学会(TOS)于 2021 年 4 月联合举办了一次多学科国际研讨会,旨在增进对慢性肾脏病(CKD)成人肥胖的理解和管理。该研讨会的基本依据是越来越多的证据表明肥胖是 CKD 的一个主要原因,也是 CKD 患者不良结局的一个主要原因,有效的肥胖治疗,包括生活方式干预、减肥药物和代谢手术,都可以产生有益的效果。与会者包括肾脏病、肥胖医学、内分泌学、糖尿病、减重/代谢手术、内镜、移植手术和营养等领域的一系列专家,以及肥胖和 CKD 患者。该小组确定了增加患者和提供者参与肥胖管理的策略,概述了一项合作行动计划,以让肾病学家和肥胖医学专家参与肥胖管理,并确定了研究机会,以解决肥胖与肾脏疾病相互作用方面知识差距的问题。该研讨会的结论为制定一种有效的、基于科学的、多学科的 CKD 患者肥胖管理方法奠定了基础。

相似文献

1
Obstacles and opportunities in managing coexisting obesity and CKD: Report of a scientific workshop cosponsored by the National Kidney Foundation and The Obesity Society.肥胖合并慢性肾脏病管理中的障碍和机遇:美国肾脏病基金会和肥胖学会联合主办的科学研讨会报告。
Obesity (Silver Spring). 2022 Dec;30(12):2340-2350. doi: 10.1002/oby.23599. Epub 2022 Oct 21.
2
Obstacles and Opportunities in Managing Coexisting Obesity and CKD: Report of a Scientific Workshop Cosponsored by the National Kidney Foundation and The Obesity Society.管理并存肥胖症和 CKD 的障碍和机遇:美国肾脏基金会和肥胖学会联合主办的科学研讨会报告。
Am J Kidney Dis. 2022 Dec;80(6):783-793. doi: 10.1053/j.ajkd.2022.06.007. Epub 2022 Oct 21.
3
Weight management strategies for those with chronic kidney disease: A consensus report from the Asia Pacific Society of Nephrology and Australia and New Zealand Society of Nephrology 2016 renal dietitians meeting.慢性肾脏病患者的体重管理策略:亚太肾脏病学会与澳大利亚和新西兰肾脏病学会2016年肾脏营养师会议的共识报告
Nephrology (Carlton). 2018 Oct;23(10):912-920. doi: 10.1111/nep.13118.
4
National Postoperative Bariatric Surgery Outcomes in Patients with Chronic Kidney Disease and End-Stage Kidney Disease.慢性肾脏病和终末期肾病患者的全国术后减重手术结局。
Obes Surg. 2019 Mar;29(3):975-982. doi: 10.1007/s11695-018-3604-2.
5
Nutrition and Obesity Impacts on Kidney Health.营养与肥胖对肾脏健康的影响。
Contrib Nephrol. 2021;199:24-42. doi: 10.1159/000517669. Epub 2021 Aug 3.
6
Treatment options for managing obesity in chronic kidney disease.管理慢性肾脏病中肥胖症的治疗选择。
Curr Opin Nephrol Hypertens. 2021 Sep 1;30(5):516-523. doi: 10.1097/MNH.0000000000000727.
7
Clinical Trial Considerations in Developing Treatments for Early Stages of Common, Chronic Kidney Diseases: A Scientific Workshop Cosponsored by the National Kidney Foundation and the US Food and Drug Administration.常见慢性肾脏病早期治疗的临床试验考虑因素:美国国家肾脏基金会和美国食品药品监督管理局共同主办的科学研讨会。
Am J Kidney Dis. 2022 Oct;80(4):513-526. doi: 10.1053/j.ajkd.2022.03.011. Epub 2022 Aug 13.
8
The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 Diabetes.肥胖症合并 2 型糖尿病患者中肾脏疾病与糖尿病缓解之间的关系。
Am J Kidney Dis. 2019 Dec;74(6):761-770. doi: 10.1053/j.ajkd.2019.05.013. Epub 2019 Jul 19.
9
CLINICAL PRACTICE GUIDELINES FOR THE PERIOPERATIVE NUTRITION, METABOLIC, AND NONSURGICAL SUPPORT OF PATIENTS UNDERGOING BARIATRIC PROCEDURES - 2019 UPDATE: COSPONSORED BY AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY, THE OBESITY SOCIETY, AMERICAN SOCIETY FOR METABOLIC & BARIATRIC SURGERY, OBESITY MEDICINE ASSOCIATION, AND AMERICAN SOCIETY OF ANESTHESIOLOGISTS - .肥胖患者减重手术围手术期营养、代谢和非手术支持临床实践指南-2019 年更新:美国临床内分泌医师协会/美国内分泌学会、肥胖协会、美国代谢与减重外科学会、肥胖医学协会和美国麻醉师协会共同赞助
Endocr Pract. 2019 Dec;25(12):1346-1359. doi: 10.4158/GL-2019-0406. Epub 2019 Nov 4.
10
Obesity Management and Chronic Kidney Disease.肥胖管理与慢性肾脏病。
Semin Nephrol. 2021 Jul;41(4):392-402. doi: 10.1016/j.semnephrol.2021.06.010.

引用本文的文献

1
Recent advances in the treatment of patients with obesity and chronic kidney disease.肥胖和慢性肾脏病患者治疗的最新进展。
Ann Med. 2023 Dec;55(1):2203517. doi: 10.1080/07853890.2023.2203517.